Back
Akero Therapeutics Stock Predictions
Sponsored
AKRO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
AKRO
Akero Therapeutics
Last Price:
31.22
Seasonality Move:
5.92%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Akero Therapeutics Stock Forecast
- Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.
- Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Akero Therapeutics Stock Undervalued?
The current Akero Therapeutics [AKRO] share price is $30.64. The Score for AKRO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal. - AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.
Akero Therapeutics Stock Rating
Buy
61
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics overpriced?
- Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
37.00
52-Week Low:
15.32
Prediction Charts
Market Cap:
2.14B
Price in USD:
30.64
Volume:
443.22K
Beta:
-0.28
Technical Analysis
SMA50:
29.63
SMA100:
27.64
SMA200:
25.21
52-Wk Change:
83.77%
Stock Predictions
-
Is Akero Therapeutics stock public?
Yes, Akero Therapeutics is a publicly traded company. -
What is the Akero Therapeutics stock quote today?
The Akero Therapeutics stock price is 30.64 USD today. -
How to buy Akero Therapeutics stock online?
You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-1 | 31.89 | 32.33 | 32.95 | 30.90 |
Nov-4 | 32.20 | 32.04 | 32.93 | 31.50 |
Nov-5 | 31.76 | 32.74 | 32.75 | 31.12 |
Nov-6 | 34.04 | 35.29 | 35.71 | 33.46 |
Nov-7 | 35.26 | 34.87 | 35.88 | 34.56 |
Nov-8 | 34.73 | 34.43 | 34.73 | 33.35 |
Nov-11 | 34.77 | 33.04 | 35.11 | 32.70 |
Nov-12 | 32.80 | 32.38 | 34.54 | 31.96 |
Nov-13 | 32.58 | 30.97 | 32.79 | 30.95 |
Nov-14 | 30.83 | 29.76 | 31.43 | 29.53 |
Nov-15 | 29.97 | 28.09 | 30.01 | 27.05 |
Nov-18 | 28.72 | 29.56 | 29.85 | 28.44 |
Nov-19 | 29.34 | 31.03 | 31.10 | 29.10 |
Nov-20 | 30.72 | 30.64 | 31.60 | 29.88 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.